French clinical-stage biotechnology and microbiome therapy company MaaT Pharma has seen success with its Phase III trial of MaaT013 meeting its primary endpoints, leading to a jump in the company ...

MaaT Pharma – Investor Relations Guilhaume DEBROAS, Ph.D. Head of Investor Relations +33 6 16 48 92 50 [email protected] MaaT Pharma – Media Relations Pauline RICHAUD Senior PR ...

Ter Maat drove a pickup truck with a 14-foot trailer hitched to the back and stacked with goods. "He's getting phone calls while he's driving down here," Katsma said.

About MaaT013 MaaT Pharma’s Microbiome Ecosystem Therapies TM (MET) are designed to leverage a full microbiome ecosystem to restore balance and maximize clinical benefits for patients with ...

A phase 3 trial of MaaT Pharma’s graft-versus-host disease (GvHD) drug candidate has hit its primary endpoint, positioning the biotech to seek approval of the microbiome therapy in Europe in mid ...

Kepher-Maat also gives New York-based IFC an additional presence in LA, he noted. Last year across the labels were 30 Shudder movies, 12 IFC Films and eight RLJE, not all released theatrically.

Libertarian Vice Presidential candidate Mike ter Maat says old habits die hard and he expects more interest following the first Presidential debate. Skip Navigation. Share on Facebook; ...

EXCLUSIVE: Strig Artist Management is bolstering its team, bringing on Christina Montojo as Manager and promoting Maat Bates from Assistant to Coordinator. Montojo moves to Strig Artist Management ...

Following its official opening on October 5, 2016, the new MAAT building reopened to the public on March 22, 2017, with two major exhibitions that take up the whole building: Utopia/Dystopia – A ...

Kepher-Maat, who is based in Los Angeles, will report to Scott Shooman, the company’s executive vice president and head of a film group encompassing three brands: IFC Films, RLJE Films and Shudder.